BOSVX
Price
$22.76
Change
-$0.03 (-0.13%)
Updated
Jul 31 closing price
Net Assets
1.31B
VISVX
Price
$58.66
Change
-$0.11 (-0.19%)
Updated
Jul 31 closing price
Net Assets
67.78B
Interact to see
Advertisement

BOSVX vs VISVX

BOSVX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
BOSVX vs. VISVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOSVX is a Hold and VISVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 67.8B vs. BOSVX (1.31B). VISVX pays higher dividends than BOSVX: VISVX (1.65) vs BOSVX (1.24). BOSVX was incepted earlier than VISVX: BOSVX (15 years) vs VISVX (28 years). BOSVX (0.64) is less costly to investors than VISVX (0.19). BOSVX is a more actively managed with annual turnover of: 31.00 vs. VISVX (25.00). BOSVX (0) and VISVX (0) have matching initial minimum investment requirements. BOSVX annual gain was more profitable for investors over the last year : 33.75 vs. VISVX (23.82). VISVX return over 5 years is better than : 46.24 vs. BOSVX (15.91).
BOSVXVISVXBOSVX / VISVX
Total Expense Ratio0.470.19247%
Annual Report Gross Expense Ratio0.640.19337%
Fund Existence15 years28 years-
Gain YTD25.12415.731160%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B67.8B2%
Annual Yield % from dividends1.241.6575%
Returns for 1 year33.7523.82142%
Returns for 3 years25.4542.7360%
Returns for 5 years15.9146.2434%
Returns for 10 years69.67135.7051%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPAX20.130.12
+0.60%
Goldman Sachs US Eq Div and Premium A
GSIMX24.30N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps Instl
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv